SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-19-000114
Filing Date
2019-06-10
Accepted
2019-06-10 16:01:24
Documents
4
Period of Report
2019-06-10
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-kpipe2ndclosing.htm 8-K 58158
2 EXHIBIT 99.1 exhibit991-pressreleasepip.htm EX-99.1 20005
3 evofembiosciencesjpegfilea12.jpg GRAPHIC 61097
4 pdla01.jpg GRAPHIC 13852
  Complete submission text file 0001618835-19-000114.txt   182877
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 19888584
SIC: 2834 Pharmaceutical Preparations